US doctor warns of misuse of prescribed stimulantsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7380.67 (Published 11 January 2003) Cite this as: BMJ 2003;326:67
- Charles Marwick
- Washington, DC
Europe is being targeted by the drugs industry as the next major market for increasing the use of stimulant drugs such as methylphenidate (Ritalin) and dexamfetamine, a Californian doctor specialising in behavioural paediatrics warned at a recent meeting of the President's Bioethics Council.
Dr Lawrence Diller has become known in the United States as a critic of the inappropriate use of stimulants such as methylphenidate for the management of children with attention deficit hyperactivity disorder. Besides its therapeutic uses methylphenidate has also attracted non-therapeutic uses: pacifying unruly children, enhancing performance, and, as Dr Diller …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial